API

50-60% savings from China and India

A large pharmaceutical company in the UK spends millions on active ingredients for over the counter medicines.

When an analysis of the spend was performed, it revealed all items were single-sourced from large European chemicals companies. The market intelligence suggested that the current prices were inflated given that Chinese and Indian companies had become extremely proficient in recent years. Some of the items were tendered using reverse online auctions, others manually negotiated.

The shortlisted companies were audited for quality, contingency and risk. As all the companies had been FDA (ICH) inspected there were few issues.

The company has since saved millions and built up relationships with low cost suppliers for future sourcing projects.

Back to Case Studies Homepage